Cordarone® (amiodarone hydrochloride) is a prescription antiarrhythmia medication approved to treat certain types of serious abnormal heartbeats known as ventricular arrhythmias. This medication comes in the form of tablets that are taken once or twice daily. It used to be available in an injectable form; however, brand-name Cordarone injections are no longer available.
Amiodarone, the active ingredient in Cordarone, can be given as an intravenous infusion, which is a slow injection into a vein. These injectable forms of amiodarone are available as either an injection that must be mixed before use or as amiodarone premixed injection (Nexterone®).
(For more details on these tablets or infusions, click Cordarone. This Web page provides a complete overview of this antiarrhythmia medication, including how it works, possible side effects, and safety concerns.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed June 18, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed June 18, 2012.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed June 18, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click